Federal Register
Notices
> Manufacturers 2008 >
Mallinckrodt, Inc
FR Doc E8-18039[Federal Register: August 6, 2008 (Volume 73, Number 152)]
[Notices] [Page 45788] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06au08-104]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 10, 2008 and published in the Federal Register on March
19, 2008 (73 FR 14840), Mallinckrodt, Inc., 3600 North Second Street, St. Louis,
Missouri 63147, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Tetrahydrocannabinols (7370)
|
I
|
Codeine-N-oxide (9053)
|
I
|
Dihydromorphine (9145)
|
I
|
Difenoxin (9168)
|
I
|
Morphine-N-oxide (9307)
|
I
|
Normorphine (9313)
|
I
|
Norlevorphanol (9634)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Methylphenidate (1724)
|
II
|
Nabilone (7379)
|
II
|
Codeine (9050)
|
II
|
Diprenorphine (9058)
|
II
|
Etorphine HCL (9059)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Diphenoxylate (9170)
|
II
|
Ecgonine (9180)
|
II
|
Hydrocodone (9193)
|
II
|
Levorphanol (9220)
|
II
|
Meperidine (9230)
|
II
|
Methadone (9250)
|
II
|
Methadone intermediate (9254)
|
II
|
Metopon (9260)
|
II
|
Dextropropoxyphene, bulk (9273)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Opium extracts (9610)
|
II
|
Opium fluid extract (9620)
|
II
|
Opium tincture (9630)
|
II
|
Opium, powdered (9639)
|
II
|
Opium, granulated (9640)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Oxymorphone (9652)
|
II
|
Noroxymorphone (9668)
|
II
|
Phenazocine (9715)
|
II
|
Alfentanil (9737)
|
II
|
Remifentanil (9739)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The firm plans to manufacture the listed controlled substances for internal
use and for sale to other companies.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Mallinckrodt, Inc.
to manufacture the listed basic classes of controlled substances is consistent
with the public interest at this time. DEA has investigated Mallinckrodt, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state
and local laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C.
823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-18039 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|